Vor Biopharma Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $464.1M
Liabilities Breakdown FY2025
Total Liabilities: $628.4M
Asset Breakdown
Total Assets: $464.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $396.5M | 85.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $533.0K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $67.1M | 14.5% |
Liabilities Breakdown
Total Liabilities: $628.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.1M | 0.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $623.3M | 99.2% |